+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Global Autoinjectors Market 2019-2023 - Product Image

Global Autoinjectors Market 2019-2023

  • ID: 4663918
  • Report
  • Region: Global
  • 113 pages
  • TechNavio
UP TO OFF
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

1 of 4

FEATURED COMPANIES

  • Amgen
  • Bayer
  • BD
  • Eli Lilly
  • Novartis
  • MORE
About Autoinjectors

An autoinjector is a medical device that delivers a fixed dose of a drug using a spring-loaded syringe.

The analysts forecast the global autoinjectors market to grow at a CAGR of 23.50% during the period 2019-2023.

Covered in this report

The report covers the present scenario and the growth prospects of the global autoinjectors market for 2019-2023. To calculate the market size, the report presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources.

The market is divided into the following segments based on geography:
  • Americas
  • APAC
  • EMEA
The report, Global Autoinjectors Market 2019-2023, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

Key vendors
  • Amgen
  • Bayer
  • BD
  • Eli Lilly
  • Novartis
Market drivers
  • Increasing prevalence of allergies and need for immediate care
  • For a full, detailed list, view the full report
Market challenges
  • Side-effects of autoinjectors
  • For a full, detailed list, view the full report
Market trends
  • Growing popularity of injectable therapies
  • For a full, detailed list, view the full report
Key questions answered in this report
  • What will the market size be in 2023 and what will the growth rate be?
  • What are the key market trends?
  • What is driving this market?
  • What are the challenges to market growth?
  • Who are the key vendors in this market space?
You can request one free hour of the analyst’s time when you purchase this market report. Details are provided within the report.
Note: Product cover images may vary from those shown
2 of 4

FEATURED COMPANIES

  • Amgen
  • Bayer
  • BD
  • Eli Lilly
  • Novartis
  • MORE
PART 01: EXECUTIVE SUMMARY

PART 02: SCOPE OF THE REPORT

PART 03: MARKET LANDSCAPE
  • Market ecosystem
  • Market characteristics
  • Market segmentation analysis
PART 04: MARKET SIZING
  • Market definition
  • Market sizing 2018
  • Market size and forecast 2018-2023
PART 05: FIVE FORCES ANALYSIS
  • Bargaining power of buyers
  • Bargaining power of suppliers
  • Threat of new entrants
  • Threat of substitutes
  • Threat of rivalry
  • Market condition
PART 06: MARKET SEGMENTATION BY APPLICATION
  • Market segmentation by application
  • Comparison by application
  • Anaphylaxis - Market size and forecast 2018-2023
  • Multiple Sclerosis - Market size and forecast 2018-2023
  • Rheumatoid Arthritis - Market size and forecast 2018-2023
  • Others - Market size and forecast 2018-2023
  • Market opportunity by application
PART 07: SEGMENTATION BY END-USER
  • Segmentation by end-user
PART 08: CUSTOMER LANDSCAPE

PART 09: GEOGRAPHIC LANDSCAPE
  • Geographic segmentation
  • Geographic comparison
  • Americas - Market size and forecast 2018-2023
  • EMEA - Market size and forecast 2018-2023
  • APAC - Market size and forecast 2018-2023
  • Key leading countries
  • Market opportunity
PART 10: DECISION FRAMEWORK

PART 11: DRIVERS AND CHALLENGES
  • Market drivers
  • Market challenges
PART 12: MARKET TRENDS

PART 13: VENDOR LANDSCAPE
  • Overview
  • Landscape disruption
PART 14: VENDOR ANALYSIS
  • Vendors covered
  • Vendor classification
  • Market positioning of vendors
  • Amgen
  • Bayer
  • BD
  • Eli Lilly
  • Novartis
PART 15: APPENDIX
  • Research methodology
  • List of abbreviations
List of Exhibits
Exhibit 01: Global medical devices market
Exhibit 02: Segments of global medical devices market
Exhibit 03: Market characteristics
Exhibit 04: Market segments
Exhibit 05: Market definition - Inclusions and exclusions checklist
Exhibit 06: Market size 2018
Exhibit 07: Global market: Size and forecast 2018-2023 ($ billions)
Exhibit 08: Global market: Year-over-year growth 2019-2023 (%)
Exhibit 09: Five forces analysis 2018
Exhibit 10: Five forces analysis 2023
Exhibit 11: Bargaining power of buyers
Exhibit 12: Bargaining power of suppliers
Exhibit 13: Threat of new entrants
Exhibit 14: Threat of substitutes
Exhibit 15: Threat of rivalry
Exhibit 16: Market condition - Five forces 2018
Exhibit 17: Application - Market share 2018-2023 (%)
Exhibit 18: Comparison by application
Exhibit 19: Anaphylaxis - Market size and forecast 2018-2023 ($ billions)
Exhibit 20: Anaphylaxis - Year-over-year growth 2019-2023 (%)
Exhibit 21: Multiple Sclerosis - Market size and forecast 2018-2023 ($ billions)
Exhibit 22: Multiple Sclerosis - Year-over-year growth 2019-2023 (%)
Exhibit 23: Rheumatoid Arthritis - Market size and forecast 2018-2023 ($ billions)
Exhibit 24: Rheumatoid Arthritis - Year-over-year growth 2019-2023 (%)
Exhibit 25: Others - Market size and forecast 2018-2023 ($ billions)
Exhibit 26: Others - Year-over-year growth 2019-2023 (%)
Exhibit 27: Market opportunity by application
Exhibit 28: Customer landscape
Exhibit 29: Market share by geography 2018-2023 (%)
Exhibit 30: Geographic comparison
Exhibit 31: Americas - Market size and forecast 2018-2023 ($ billions)
Exhibit 32: Americas - Year-over-year growth 2019-2023 (%)
Exhibit 33: EMEA - Market size and forecast 2018-2023 ($ billions)
Exhibit 34: EMEA - Year-over-year growth 2019-2023 (%)
Exhibit 35: APAC - Market size and forecast 2018-2023 ($ billions)
Exhibit 36: APAC - Year-over-year growth 2019-2023 (%)
Exhibit 37: Key leading countries
Exhibit 38: Market opportunity
Exhibit 39: Impact of drivers and challenges
Exhibit 40: Vendor landscape
Exhibit 41: Landscape disruption
Exhibit 42: Vendors covered
Exhibit 43: Vendor classification
Exhibit 44: Market positioning of vendors
Exhibit 45: Amgen - Overview
Exhibit 46: Amgen - Business segments
Exhibit 47: Amgen - Organizational developments
Exhibit 48: Amgen - Geographical focus
Exhibit 49: Amgen - Key offerings
Exhibit 50: Bayer - Overview
Exhibit 51: Bayer - Business segments
Exhibit 52: Bayer - Organizational developments
Exhibit 53: Bayer - Geographical focus
Exhibit 54: Bayer - Segment focus
Exhibit 55: Bayer - Key offerings
Exhibit 56: BD - Overview
Exhibit 57: BD - Business segments
Exhibit 58: BD - Organizational developments
Exhibit 59: BD - Geographical focus
Exhibit 60: BD - Segment focus
Exhibit 61: BD - Key offerings
Exhibit 62: Eli Lilly - Overview
Exhibit 63: Eli Lilly: Business segments
Exhibit 64: Eli Lilly: Organizational developments
Exhibit 65: Eli Lilly - Geographical focus
Exhibit 66: Eli Lilly - Segment focus
Exhibit 67: Eli Lilly - Key offerings
Exhibit 68: Novartis - Overview
Exhibit 69: Novartis - Business segments
Exhibit 70: Novartis: Organizational developments
Exhibit 71: Novartis - Geographical focus
Exhibit 72: Novartis - Segment focus
Exhibit 73: Novartis - Key offerings
Exhibit 74: Validation techniques employed for market sizing
Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4

FEATURED COMPANIES

  • Amgen
  • Bayer
  • BD
  • Eli Lilly
  • Novartis
  • MORE
The author of the report recognizes the following companies as the key players in the global autoinjectors market: Amgen, Bayer, BD, Eli Lilly, and Novartis.

Commenting on the report, an analyst from the research team said: “One trend in the market is growing popularity of injectable therapies. Injectable therapies account for a significant share of the global drug market. Factors boosting the growth of the market are high-value biologics, such as monoclonal antibodies and peptides, which require injection due to their size and sensitivity Injection-based drug delivery targets areas such as immuno-oncology, diabetes, and auto-immune diseases.”

According to the report, one driver in the market is increasing prevalence of allergies and need for immediate care. Globally, the prevalence of allergies to food items, pollens, food additives, latex, and dust and the risk of contracting anaphylaxis caused by these factors are increasing. According to CDC, allergies are the sixth leading cause of chronic illness in the US with an annual expenditure of more than S18 billion.

Further, the report states that one challenge in the market is side-effects of autoinjectors. The use of autoinjectors cause several side-effects, such as infection, hypertension, hypotension, myalgia, headache, and diarrhea Patients with chemotherapy-induced anemia exhibit fatigue, edema, nausea, vomiting, fever, and increased occurrence of hypertension.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
Note: Product cover images may vary from those shown
5 of 4
  • Amgen
  • Bayer
  • BD
  • Eli Lilly
  • Novartis
Note: Product cover images may vary from those shown
Adroll
adroll